Display options
Cite
Ott S, Lanmüller P, Nersesian G, et al. Management of increased systemic flow requirements in patients with left ventricular assist devices. Ann Cardiothorac Surg. 2021;10(3):399-401doi: 10.21037/acs-2021-cfmcs-37.
Ott, S., Lanmüller, P., Nersesian, G., Starck, C. T., O'Brien, B., Falk, V., & Potapov, E. (2021). Management of increased systemic flow requirements in patients with left ventricular assist devices. Annals of cardiothoracic surgery, 10(3), 399-401. https://doi.org/10.21037/acs-2021-cfmcs-37
Ott, Sascha, et al. "Management of increased systemic flow requirements in patients with left ventricular assist devices." Annals of cardiothoracic surgery vol. 10,3 (2021): 399-401. doi: https://doi.org/10.21037/acs-2021-cfmcs-37
Ott S, Lanmüller P, Nersesian G, Starck CT, O'Brien B, Falk V, Potapov E. Management of increased systemic flow requirements in patients with left ventricular assist devices. Ann Cardiothorac Surg. 2021 May;10(3):399-401. doi: 10.21037/acs-2021-cfmcs-37. PMID: 34159124; PMCID: PMC8185390.
Copy Download .nbib Format: NLM
Share it on

Ann Cardiothorac Surg. 2021 May;10(3):399-401. doi: 10.21037/acs-2021-cfmcs-37.

Management of increased systemic flow requirements in patients with left ventricular assist devices.

Annals of cardiothoracic surgery

Sascha Ott, Pia Lanmüller, Gaik Nersesian, Christoph T Starck, Benjamin O'Brien, Volkmar Falk, Evgenij Potapov

Affiliations

  1. Department of Cardiac Anesthesiology and Intensive Care Medicine, German Heart Center Berlin, Berlin, Germany.
  2. Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.
  3. DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.
  4. Steinbeis University Berlin, Institute (STI) of Cardiovascular Perfusion, Berlin, Germany.
  5. Department of Cardiac Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  6. William Harvey Research Institute, London, UK.
  7. Department of Cardiothoracic Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  8. Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  9. Translational Cardiovascular Technologies, Institute of Translational Medicine, Department of Health Sciences and Technology, Swiss Federal Institute of Technology (Eth), Zürich, Switzerland.

PMID: 34159124 PMCID: PMC8185390 DOI: 10.21037/acs-2021-cfmcs-37

[No abstract available.]

Conflict of interest statement

Conflicts of Interest: SO declares Research and study funds from Novartis Pharma GmbH. CTS declares payment to his institution related to his activity as speaker fees, honoraria, consultancy, advisory

References

  1. J Trauma. 1987 Nov;27(11):1240-60 - PubMed
  2. Scand Cardiovasc J. 2020 Oct;54(5):306-314 - PubMed
  3. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2769-78 - PubMed
  4. J Surg Res. 1981 Dec;31(6):475-81 - PubMed
  5. Minerva Anestesiol. 2003 Apr;69(4):237-44 - PubMed
  6. Mol Cell Biochem. 2021 Mar;476(3):1313-1326 - PubMed
  7. Resuscitation. 2008 Sep;78(3):355-8 - PubMed

Publication Types